Literature DB >> 2503016

[Effects of anticonvulsants on cellular immunity].

Y Okamoto1, K Shimizu, K Tamura, M Yamada, Y Matsui, T Hayakawa, H Mogami.   

Abstract

The effects of anticonvulsants on cellular immunity were examined in murine models. Fresh splenocytes were obtained from mice which had been intraperitoneally given 1 mg of phenytoin, 2 mg of phenobarbital, or 20mg of valproate for 28 days. The serum concentration of phenytoin, phenobarbital and valproate in these animals were 10-20 micrograms/ml, 30-40 micrograms/ml and 50-70 micrograms/ml, respectively. The proliferative response of splenocytes to mitogens was assessed by 3H-thymidine incorporation. The cytotoxic activities of cells such as natural killer (NK) cells, cytotoxic T lymphocytes (CTL), and lymphokine-activated killer (LAK) cells were estimated by a 4 hr-51Cr release assay. Phenytoin suppressed lymphocyte proliferation, NK activity, and CTL activity, but never LAK activity. Phenobarbital suppressed proliferative response to rIL-2 and CTL activity, but did not suppress NK activity nor LAK activity. In turn sodium pyruvate never suppressed any activity on cellular immunity.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2503016

Source DB:  PubMed          Journal:  No To Shinkei        ISSN: 0006-8969


  3 in total

Review 1.  Immunological adverse effects of anticonvulsants. What is their clinical relevance?

Authors:  F De Ponti; S Lecchini; M Cosentino; C M Castelletti; A Malesci; G M Frigo
Journal:  Drug Saf       Date:  1993-03       Impact factor: 5.606

2.  Phenytoin as a novel anti-vitiligo weapon.

Authors:  M R Namazi
Journal:  J Autoimmune Dis       Date:  2005-11-22

3.  Skin and soft tissue infection by Mycobacterium intracellulare in an immunocompetent patient.

Authors:  Alessio Pampaloni; Salvatore Tosto; Maria Elena Locatelli; Adele Gentile; Daniele Scuderi; Andrea Marino; Federica Cosentino; Vittoria Moscatt; Giuseppe Nunnari; Bruno Cacopardo
Journal:  IDCases       Date:  2020-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.